Affinity Asset Advisors, LLC Bluebird Bio, Inc. Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 50,000 shares of BLUE stock, worth $389,500. This represents 0.51% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$389,500% of portfolio
0.51%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
150Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$81.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$36.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$36.4 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$29.9 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $601M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...